Christopher C. Shelton
- Pharmacology top 1%
- Molecular Biology
- Physiology top 10%
- Cellular and Molecular Neuroscience top 10%
- Oncology
- Co-authors
- Aron H. LichtmanBenjamin F. CravattTushar AdvaniDonmienne LeungChristophe HardouinDale L. BogerAlan SaghatelianYue‐Ming Li
- Topics
- Alzheimer's disease research and treatments (3 papers)Computational Drug Discovery Methods (3 papers)Cannabis and Cannabinoid Research (3 papers)
- Partner nations
- United States
In The Last Decade
Christopher C. Shelton
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Pharmacology 583
- Molecular Biology 477
- Physiology 266
- Cellular and Molecular Neuroscience 238
- Oncology 158
Countries citing papers authored by Christopher C. Shelton
This map shows the geographic impact of Christopher C. Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Shelton more than expected).
Fields of papers citing papers by Christopher C. Shelton
This network shows the impact of papers produced by Christopher C. Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Shelton. The network helps show where Christopher C. Shelton may publish in the future.
Co-authorship network of co-authors of Christopher C. Shelton
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Shelton. A scholar is included among the top collaborators of Christopher C. Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Shelton. Christopher C. Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 115 | |
| 2 | 224 | |
| 3 | 14 | |
| 4 | 18 | |
| 5 | 67 | |
| 6 | 2 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 27 | |
| 10 | 135 | |
| 11 | 255 | |
| 12 | 282 |
About Christopher C. Shelton
Christopher C. Shelton is a scholar working on Pharmacology, Toxicology and Computational Theory and Mathematics, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (3 papers), Computational Drug Discovery Methods (3 papers) and Cannabis and Cannabinoid Research (3 papers). The work is most often cited by research in Toxicology (131 citations), Pharmacology (583 citations) and Cellular and Molecular Neuroscience (238 citations). Christopher C. Shelton has collaborated with scholars based in United States. Frequent co-authors include Aron H. Lichtman, Benjamin F. Cravatt, Tushar Advani, Donmienne Leung, Christophe Hardouin, Dale L. Boger, Alan Saghatelian, Yue‐Ming Li, Li-Xuan Qin and Philip B. Paty. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.